质子泵抑制剂使用与医院感染关联性病例对照研究
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R181.3+2

基金项目:

国家自然科学基金项目(72064002);中央高校基本科研业务费专项基金项目(31920240079);甘肃卫生行业科研计划(GSWSKY2023-16);甘肃省卫生健康行业科技创新重大项目(GSWSZD2025-14)


A case-control study on the relationship between use of proton pump inhi-bitors and healthcare-associated infection
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    目的 探讨住院患者使用质子泵抑制剂(PPIs)与医院感染发生的关系,为预防和控制医院感染提供理论依据。方法 选取2023年1月—2024年12月甘肃省3所不同层级公立医院报告的医院感染病例为病例组。采用分层随机抽样方法,以查尔森合并症指数(CCI)为分层依据将病例组分为4个层次。同期从未发生医院感染的病例中依据CCI分层抽取相同数量的病例作为对照组,进行回顾性病例-对照研究。探讨医院感染危险因素,及PPIs用药时间与医院感染发生风险剂量-反应关系。结果 病例组患者PPIs使用率高于对照组(45.36% VS 29.57%),差异有统计学意义(P<0.001,OR=1.98)。多因素logistic回归结果表明,PPIs使用的校正OR值为1.78(P<0.001),其带来的感染风险与泌尿道插管等侵入性操作相当。病例组患者PPIs中位用药时间为9 d,长于对照组的8 d(P<0.001);用药时间延长与感染风险升高呈剂量-反应关系(用药时间>14 d时,OR=4.59)。此外,感染组患者口服联合静脉注射给药的比例高于对照组,泌尿道插管、中心静脉置管亦增加医院感染风险(均P<0.05)。结论 住院患者使用PPIs会增加医院感染风险,且该风险随用药时间延长而升高。给药方式、住院时间及泌尿道插管、中心静脉置管等因素均影响医院感染的发生。

    Abstract:

    Objective To evaluate the relationship between the use of proton pump inhibitors (PPIs) and the occurrence of healthcare-associated infection (HAI)in hospitalized patients, providing a theoretical basis for the prevention and control of HAI. Methods HAI cases reported from 3 public hospitals of different classes in Gansu Province between January 2023 and December 2024 were selected as the case group. The stratified random sampling method was adopted, the case group was divided into four levels based on the Charlson comorbidity index (CCI). An equal number of cases without HAI during the same period were selected as control group through CCI stratification, and a retrospective case-control study was conducted. The risk factors for HAI as well as the dose-response relationship between duration of PPI use and HAI occurrence were explored. Results The use rate of PPIs in patients in the case group was higher than that in the control group (45.36% vs 29.57%), with a statistically significant difference (P<0.001, OR=1.98). Multivariate logistic regression results indicated that the adjusted OR value for use of PPIs was 1.78 (P<0.001), its infection risk was comparable to that of invasive procedures such as urinary catheterization. The median duration of PPI use in patients in the case group was 9 days, which was longer than the 8 days in the control group (P<0.001). An extension of duration of PPI use and increasing of infection risk presented a dose-response relationship (OR=4.59 when the duration of PPI use exceeded 14 days). Additionally, the proportion of oral combined with intravenous administration in patients in the case group was higher than that in the control group, and urinary catheterization and central venous catheterization also increased the risk of HAI (all P<0.05). Conclusion The use of PPIs in hospitalized patients can increase the risk of HAI, and this risk rises with prolonged medication duration. Factors such as administration method, length of hospital stay, as well as urinary catheterization and central venous catheterization also impact the occurrence of HAI.

    参考文献
    相似文献
引用本文

段凯悦,张小亮,姚程洪,等.质子泵抑制剂使用与医院感染关联性病例对照研究[J]. 中国感染控制杂志,2026,25(5):750-755. DOI:10.12138/j. issn.1671-9638.20267403.
DUAN Kaiyue, ZHANG Xiaoliang, YAO Chenghong, et al. A case-control study on the relationship between use of proton pump inhi-bitors and healthcare-associated infection[J]. Chin J Infect Control, 2026,25(5):750-755. DOI:10.12138/j. issn.1671-9638.20267403.

复制
分享
文章指标
  • 摘要阅读次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-09-01
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-05-29
  • 出版日期: 2026-05-28